Specimen Validity Testing Market - By Product (Product {Assay Kits, Reagents and Calibrators, Disposables}, Service), By Type (Laboratory Testing, Rapid/POC Testing), By End-use (Drug Screening Laboratories, Drug Rehabilitation Centers, Pain Management Centers) & Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSpecimen Validity Testing Market - By Product (Product {Assay Kits, Reagents and Calibrators, Disposables}, Service), By Type (Laboratory Testing, Rapid/POC Testing), By End-use (Drug Screening Laboratories, Drug Rehabilitation Centers, Pain Management Centers) & Forecast, 2023 – 2032
Specimen Validity Testing Market Size
Specimen Validity Testing Market size was valued at around USD 2.4 billion in 2022 and is projected to reach over USD 4.7 billion by the end of 2032. This incremental growth rate is owing to increasing incidence of illicit drug abuse coupled with rising awareness regarding specimen validity testing and surging demand for rapid and point of care testing.
Technological advancements pertaining to specimen validity testing in urine test to analyze adulterants, substitution and dilution is expected to augment the market growth in the forecasted timeframe. Rising healthcare spending for providing better healthcare infrastructure and increasing disposable income are some of the major factors responsible for increased adoption of specimen validity testing devices and services across the world.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Specimen Validity Testing Market Size in 2022 | USD 2.4 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 6.8% |
| 2032 Value Projection | USD 4.7 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 180 |
| Tables, Charts & Figures | 340 |
| Segments covered | Product & Services, Type, End-use and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Specimen validity testing (SVT) is a process used to assess the integrity and authenticity of biological samples, typically urine, in various testing scenarios, such as drug testing. This testing is intended to verify that the submitted sample has not been adulterated, substituted, diluted, or tampered with in any way that could potentially alter the test results.
Money can be a big issue when it comes to specimen validity testing (SVT). This kind of test checks if samples are real and haven't been tampered with, but it can cost more than just regular drug testing. SVT needs special equipment and chemicals to check things like temperature, pH, and specific gravity. These can be expensive to buy, maintain, and calibrate. For example, a creatinine test calibrator alone can cost between $800 and $2,000, depending on the test. These high costs can make it hard for developing countries to use SVT, as they may not have enough funding. This can slow down the growth of the market for SVT.
COVID-19 Impact
In early 2020, the world was hit by the COVID-19 pandemic, which had a big impact on healthcare around the world. This included labs and rehab centers, which had to deal with a lot of challenges and changes because of the virus. One of the things that was affected was the testing of samples to make sure they were valid. This is important to make sure that the results of the tests are accurate and reliable. But with the pandemic, it became harder to manage these tests, as people were getting sick and travel was restricted. As a result, the industry that does these tests saw a big drop in business in the first half of 2020. However, as the pandemic started to slow down and healthcare facilities started to get back to normal, the industry started to recover. By the end of the year, the number of tests being done was back to where it was before the pandemic. So, while the pandemic hurt the industry at first, it's good to see that it's now back on its feet as the situation improves.
Specimen Validity Testing Market Trends
As drug abuse continues to surge, it's like a dark cloud hanging over us. This is a major concern for our health and well-being. Just think about it - in 2021, a whopping 52.5 million people worldwide were hitting the bong or smoking joints! That's a lot of pot! So, to keep ourselves safe, workplaces, cops, and rehab centers are cracking down on drug testing. They need to make sure people are playing by the rules and getting the help they need. And with more drug tests, there's a growing demand for "specimen validity testing." This is basically like a detective for pee samples. It checks to make sure they haven't been tampered with or faked. On top of that, things like a better economy, new laws, and fancy new drug testing gadgets are all giving a boost to the drug testing industry. It's like a perfect storm for those who want to sniff out drug users.
Specimen Validity Testing Market Analysis
The specimen validity testing (SVT) market is divided into two main categoriesproducts and services. The product segment includes assay kits, reagents and calibrators, and disposables. In 2022, products led the market, covering over 67% of it. This dominance is driven by the benefits of products in detecting issues with samples early on. They can spot tampering or adulteration in different ways, like dilution, substitution, or adding substances to hide other things. SVT products help drug testing be more accurate and prevent people from trying to change or adulterate samples.
The specimen validity testing market is split into two main typeslab testing and rapid/POC testing. In 2022, lab testing was the bigger part of the market, taking up over 60% of the total share. Why is lab testing so popular? It's got to do with all the pros it offers for checking if samples are valid. These labs are decked out with the latest tech and have the smartest people on staff. They also give you a complete rundown of your sample to make sure it's the real deal. This in-depth analysis can catch any weirdness or problems in the sample, which means you can trust the results of your drug test. Plus, lab testing is getting even better thanks to new research and development. This means lab results will be even more accurate and reliable in the future, and experts will be there to help you figure out what they mean. So, the market for lab testing is set to keep growing in the years to come.
When it comes to checking for drug use, different places like drug screening labs, rehab centers, pain management clinics, and so on play a role. In 2022, drug screening labs had the biggest slice of the market. And they're expected to keep growing at a solid 6.5% per year until 2032. Why are drug screening labs so popular? Because they have fancy equipment and a wide range of tests that can catch all sorts of drug use. This makes things easier for everyone involved. Another thing driving this growth is that more and more people are trying to fool drug tests by adding things to their urine. So, drug screening labs need to stay on top of their game with better testing tools and methods. All of this means that drug screening labs will keep buying the latest and greatest testing products, which will make the overall market even bigger.
The U.S. market for testing the validity of urine samples used in drug tests is expected to grow significantly in the coming years. In 2022, the market was dominated by a few major companies, and this trend is expected to continue. The main reasons for this growth includeAn increase in the number of people using illegal drugs A growing awareness of the importance of specimen validity testing Stricter regulations on drug screening More awareness about prescription drug abuse A growing number of people struggling with drug addiction In addition, government funding for drug screening is expected to increase, which will also boost the market for specimen validity testing. All of these factors are expected to lead to a positive growth in the market for specimen validity testing in the United States.
Specimen Validity Testing Market Share
Some of the major players operating in the specimen validity testing market are
- Abbott Laboratories
- ACM Global Laboratories
- Alfa Scientific Designs, Inc.
- American Bio Medica Corporation
- Danaher Corporation
- Express Diagnostics
- GenomeWeb LLC.
- Genway Biotech, Inc.
- LabCorp
- Premier Biotech, Inc.
- Quest Diagnostics Incorporated.
- Sciteck, Inc.
- SureHire
- Thermo Fisher Scientific Inc.
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
Specimen Validity Testing Industry News
- In April 2020, Nona Scientific announced the launch of NonaClear 2.0, an advance specimen validity testing product. This test can accurately detect synthetic urine, as well as multiple methods of subversion. This innovative product launch helped the company to increase their product portfolio and enhance their business revenue.
- In June 2018, ACM Global Laboratories announced the acquisition of ABS Laboratories, a manufacturer and provider of medical devices including specimen validity testing equipment. This acquisition helped the company to increase their market presence and enhance their customer base.
Specimen validity testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Product & Services
- Product
- Assay Kits
- Reagents and Calibrators
- Disposables
- Service
By Type
- Laboratory Testing
- Rapid/POC Testing
By End-use
- Drug Screening Laboratories
- Drug Rehabilitation Centers
- Pain Management Centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Egypt
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy